NTRA
Natera, Inc.
+15.50 (+4.49%)360.84USD536K成交股數52.0B市值–本益比(近四季)19.2股價營收比+37.7%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 125 · 91.9M · 9 |
| 其中 10b5-1 計畫賣出 | 125 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 155M |
| 近 180 天 淨額 | −155M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.2K | 343.56 | 770K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.8K | 341.41 | 619K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 8.1K | 348.65 | 2.8M | 2.1M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.0K | 342.18 | 669K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.5K | 340.25 | 867K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.0K | 350.01 | 700K | 0 | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 800 | 351.25 | 281K | 2.1M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.7K | 347.81 | 939K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.5K | 339.24 | 502K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 4.2K | 349.51 | 1.5M | 2.1M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.7K | 345.38 | 933K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.1K | 346.68 | 389K | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 5.8K | 344.49 | 2.0M | 2.2M | SEC |
| 2026-09-15 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 14.5K | 350.81 | 5.1M | 2.1M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.8K | 334.24 | 942K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.5K | 328.09 | 504K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.7K | 341.35 | 922K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.2K | 333.07 | 748K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.1K | 339.37 | 713K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.0K | 340.31 | 681K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.4K | 338.30 | 474K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.0K | 332.02 | 332K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 3.8K | 335.18 | 1.3M | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.2K | 337.17 | 744K | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 6.0K | 329.12 | 2.0M | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 8.5K | 336.27 | 2.8M | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 3.5K | 330.98 | 1.2M | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 4.1K | 342.51 | 1.4M | 2.2M | SEC |
| 2026-09-14 | 09-17 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 6.2K | 330.05 | 2.0M | 2.2M | SEC |
| 2026-09-11 | 09-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 3.6K | 326.11 | 1.2M | 2.3M | SEC |
| 2026-09-11 | 09-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 10.6K | 327.14 | 3.5M | 2.3M | SEC |
| 2026-09-11 | 09-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 800 | 325.01 | 260K | 2.3M | SEC |
| 2026-09-11 | 09-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 17.9K | 327.97 | 5.9M | 2.2M | SEC |
| 2026-09-11 | 09-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 1.3K | 329.62 | 429K | 2.2M | SEC |
| 2026-09-11 | 09-11 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 15.8K | 328.95 | 5.2M | 2.2M | SEC |
| 2026-09-02 | 09-03 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 15.2K | 326.89 | 5.0M | 111K | SEC |
| 2026-09-01 | 09-03 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 1.0K | 319.76 | 320K | 128K | SEC |
| 2026-09-01 | 09-03 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 1.7K | 320.99 | 545K | 98.2K | SEC |
| 2026-09-01 | 09-03 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 600 | 321.91 | 193K | 126K | SEC |
| 2026-09-01 | 09-03 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 1.4K | 320.92 | 449K | 127K | SEC |
| 2026-08-10 | 08-28 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | S 公開市場賣出(10b5-1) | 6.5K | 321.53 | 2.1M | 197K | SEC |
| 2026-08-10 | 08-14 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 6.0K | 325.32 | 2.0M | 230K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 200 | 317.97 | 64K | 237K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 100 | 318.63 | 32K | 237K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 850 | 314.25 | 267K | 243K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 5.1K | 316.61 | 1.6M | 237K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 600 | 315.32 | 189K | 242K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 900 | 313.07 | 282K | 244K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 489 | 320.90 | 157K | 236K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 400 | 311.88 | 125K | 245K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 400 | 310.23 | 124K | 245K | SEC |
| 2026-08-07 | 08-07 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 100 | 308.40 | 31K | 246K | SEC |
| 2026-08-07 | 08-07 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 2.0K | 320.90 | 642K | 2.0K | SEC |
| 2026-08-06 | 08-28 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | A 獲配股票 | 20.0K | – | – | 204K | SEC |
| 2026-08-04 | 08-05 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 478 | 274.22 | 131K | 51.6K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 296 | 267.08 | 79K | 101K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 80 | 265.27 | 21K | 101K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 676 | 263.86 | 178K | 101K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 70 | 261.03 | 18K | 102K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 160 | 259.98 | 42K | 102K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 1.2K | 267.99 | 317K | 102K | SEC |
| 2026-08-03 | 08-05 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 612 | 268.22 | 164K | 99.9K | SEC |
| 2026-08-03 | 08-05 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 317 | 267.99 | 85K | 52.1K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 300 | 259.98 | 78K | 132K | SEC |
| 2026-08-03 | 08-05 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S 公開市場賣出(10b5-1) | 731 | 267.99 | 196K | 2.3M | SEC |
| 2026-08-03 | 08-05 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | S 公開市場賣出(10b5-1) | 334 | 267.99 | 90K | 170K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 410 | 267.99 | 110K | 132K | SEC |
| 2026-08-03 | 08-05 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | S 公開市場賣出(10b5-1) | 295 | 267.99 | 79K | 184K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 128 | 268.70 | 34K | 129K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 1.2K | 267.79 | 330K | 129K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 192 | 265.28 | 51K | 130K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 947 | 263.94 | 250K | 131K | SEC |
| 2026-08-03 | 08-05 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S 公開市場賣出(10b5-1) | 200 | 261.49 | 52K | 132K | SEC |
| 2026-08-03 | 08-05 | Sheena Jonathan | Director,Other | S 公開市場賣出(10b5-1) | 109 | 267.99 | 29K | 246K | SEC |
| 2026-07-29 | 07-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 1.9K | 249.38 | 465K | 52.4K | SEC |
| 2026-07-28 | 07-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 1.2K | 254.07 | 315K | 55.5K | SEC |
| 2026-07-28 | 07-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 170 | 254.33 | 43K | 54.3K | SEC |
| 2026-07-28 | 07-29 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 1.0K | 253.77 | 256K | 54.5K | SEC |
| 2026-07-28 | 07-29 | Chapman Steven Leonard | CEO AND PRESIDENT | S 公開市場賣出(10b5-1) | 3.6K | 254.07 | 910K | 103K | SEC |
| 2026-07-28 | 07-29 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | S 公開市場賣出(10b5-1) | 1.0K | 254.07 | 255K | 170K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 12.9M | 3.5B | 新進 | 新進 |
| BlackRock, Inc. | 10.9M | 3.0B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.2M | 1.7B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.8M | 1.6B | 新進 | 新進 |
| FMR LLC | 5.5M | 1.5B | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.0M | 1.1B | 新進 | 新進 |
| STATE STREET CORP | 3.7M | 992M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8M | 745M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 2.7M | 740M | 新進 | 新進 |
| Castle Hook Partners LP | 2.6M | 705M | 新進 | 新進 |
| Coatue COATUE MANAGEMENT LLC | 2.5M | 680M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 2.3M | 628M | 新進 | 新進 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.2M | 602M | 新進 | 新進 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.0M | 535M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 1.8M | 496M | 新進 | 新進 |
| FRED ALGER MANAGEMENT, LLC | 1.8M | 483M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.7M | 467M | 新進 | 新進 |
| Sofinnova Investments, Inc. | 1.6M | 421M | 新進 | 新進 |
| Capital World Investors | 1.5M | 408M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.5M | 408M | 新進 | 新進 |
| MAVERICK CAPITAL LTD | 1.4M | 368M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 1.3M | 347M | 新進 | 新進 |
| MORGAN STANLEY | 1.3M | 346M | 新進 | 新進 |
| FEDERATED HERMES, INC. | 1.1M | 309M | 新進 | 新進 |
| Clearbridge Investments, LLC | 1.0M | 276M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 846 +80 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 846 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 137M · 95.2% |
| 合計季末市值 | 33.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 5.5M |
|---|---|
| 與上期比 | +28.4% |
| 佔流通股數 | 3.83% |
| 日均成交量 | 1.3M |
| 回補天數 | 4.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 5.5M | +28.4% | 3.83% | 1.3M | 4.4 |
| 2026-08-14 | 4.3M | -1.6% | 2.98% | 1.6M | 2.6 |
| 2026-07-31 | 4.4M | -12.1% | 3.03% | 932K | 4.7 |
| 2026-07-15 | 5.0M | -14.7% | 3.44% | 1.4M | 3.6 |
| 2026-06-30 | 5.8M | +34.9% | 4.04% | 2.1M | 2.8 |
| 2026-06-15 | 4.3M | +19.4% | 2.99% | 1.1M | 4.0 |
| 2026-05-29 | 3.6M | -4.5% | 2.51% | 1.6M | 2.2 |
| 2026-05-15 | 3.8M | -6.0% | 2.63% | 1.9M | 2.0 |
| 2026-04-30 | 4.0M | +6.7% | 2.79% | 1.2M | 3.3 |
| 2026-04-15 | 3.8M | -22.5% | 2.62% | 1.4M | 2.7 |
| 2026-03-31 | 4.9M | +47.2% | 3.38% | 1.2M | 4.1 |
| 2026-03-13 | 3.3M | +10.6% | 2.29% | 1.3M | 2.5 |
| 2026-02-27 | 3.0M | -8.8% | 2.07% | 1.0M | 2.9 |
| 2026-02-13 | 3.3M | -3.7% | 2.27% | 1.3M | 2.6 |
| 2026-01-30 | 3.4M | -1.5% | 2.36% | 986K | 3.5 |
| 2026-01-15 | 3.5M | -27.2% | 2.40% | 1.2M | 2.8 |
| 2025-12-31 | 4.7M | +39.8% | 3.29% | 1.0M | 4.6 |
| 2025-12-15 | 3.4M | -15.5% | 2.36% | 1.2M | 2.8 |
| 2025-11-28 | 4.0M | +7.0% | 2.79% | 2.0M | 2.1 |
| 2025-11-14 | 3.8M | -3.9% | 2.61% | 1.6M | 2.3 |
| 2025-10-31 | 3.9M | +1.1% | 2.71% | 1.2M | 3.4 |
| 2025-10-15 | 3.9M | -29.1% | 2.68% | 1.1M | 3.5 |
| 2025-09-30 | 5.5M | +43.7% | 3.78% | 1.2M | 4.7 |
| 2025-09-15 | 3.8M | +2.3% | 2.63% | 947K | 4.0 |
| 2025-08-29 | 3.7M | -11.1% | 2.57% | 1.0M | 3.7 |
| 2025-08-15 | 4.2M | +5.1% | 2.89% | 1.9M | 2.2 |